Search

everythinglearnresearchcommunity

for

Search:↓

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Effective treatments for severe alopecia areata are still lacking.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Psoriasis can cause temporary or permanent hair loss.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

No systemic treatment for alopecia areata has strong evidence of effectiveness.